In Re: Modafinil AntiTrust v., No. 15-3475 (3d Cir. 2016)
Annotate this CaseThis opinion or order relates to an opinion or order originally issued on September 13, 2016.
Download PDF
UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT _____________ No. 15-3475 _____________ IN RE: MODAFINIL ANTITRUST LITIGATION Mylan Laboratories, Inc.; Mylan Pharmaceuticals Inc.; Ranbaxy Laboratories, Ltd; Ranbaxy Pharmaceuticals, Inc., Appellants ______________ On Appeal from the United States District Court for the Eastern District of Pennsylvania District Court No. 2-06-cv-01797 District Judge: The Honorable Mitchell S. Goldberg _________________ Before: SMITH, JORDAN, and RENDELL, Circuit Judges _________________ ORDER AMENDING OPINION _________________ The opinion filed September 13, 2016 is amended solely as to the listing of Paul B. Hewitt, Esq. and Catherine Creely, Esq. on the opinion and not as to the substance of the opinion itself. Mr. Hewitt and Ms. Creely should have been listed as members of Akin Gump Strauss Hauer & Feld in Washington, DC. Mr. Hewitt was omitted from the listing of counsel and Ms. Creely was erroneously listed as a member of Cohn & Marks in Washington, DC. The opinion is amended as follows: Paul B. Hewitt C. Fairley Spillman Catherine E. Creely Akin Gump Strauss Hauer & Feld 1333 New Hampshire Avenue, N.W. Suite 400 Washington, DC 20036 For the Court, Marcia M. Waldron, Clerk Date: September 29, 2016 PDB/cc: All Counsel of Record
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
